Reply to Chu et al., “Adoption of the New CLSI Fluoroquinolone Breakpoints for Enterobacteriaceae ”
Abstract
We thank Chu and colleagues ([10][1]) for highlighting the potential impact of the 2019 revised Clinical and Laboratory Standards Institute (CLSI) Enterobacteriaceae fluoroquinolone breakpoints on the reporting of other members of this antibiotic class, in this case, nalidixic acid. As noted by...
Paper Details
Title
Reply to Chu et al., “Adoption of the New CLSI Fluoroquinolone Breakpoints for Enterobacteriaceae ”
Published Date
Nov 1, 2019
Volume
57
Issue
11
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History